chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse and refers to a 63-year-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-DEC-2017, the patient was vaccinated with an expired dose of ZOSTAVAX lot# M037656 and expiration date: 29-NOV-2017 (dose and route of administration were not reported) reconstituted with sterile diluent which was not expired. There were no adverse effects reported.
sweaty, light headed, felt like I was going to passout. Had to lay down. BP taken (normal). After 3 mins felt better.  on 10/16/2021 have swollen, sore lymph node on side of injection.
redness and swelling at the site about 3" wide and 1" high that has persisted (albeit reduced since Saturday) through Monday (for a shot received Friday morning). I have not previously had site reactions to covid vaccines.
Bumps on the upper right under arm; Itches off and on or when clothes are touching; This is a spontaneous report from a non-contactable consumer, the patient. A 65-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 14:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes in her family, but not to the patient. The patient was allergic to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medication. On 10Apr2021, the patient experienced bumps on the upper right under arm and they sometimes got bigger and smaller. They itched off and on or when clothes were touching. The events did not result in doctor or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events bumps on the upper right under arm and they itched was not resolved at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
nausea & vomiting, h/a, weakness, blurred vision; treated w/APAP & resolved;
slightly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (slightly sore arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 025C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ASCORBIC ACID (VIT C), CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and VITAMIN D3 for an unknown indication.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced PAIN IN EXTREMITY (slightly sore arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (slightly sore arm) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       This case was linked to MOD-2021-104726 (Patient Link).
The only side effect I had was my head was a little hot but really did not have any fever, and two days after the shot my breasts began to lactate and grew a cup size. I am not pregnant and my child is 8 years old.
Systemic: Confusion-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Medium, Systemic: Shakiness-Mild, Additional Details: Pt was okay for 2 minutes and then fainted. LOC for 10-15 seconds, woken up to sniffing alcohol swab, CapriSun provided to raise blood sugar and cool her off. Another one was provided to use as an icepack as she was very hot. She recovered after 5 mins, refused medical attention.
Extremely nauseous; Diarrhea so bad I thought I was going to pass out; Diarrhea so bad I thought I was going to pass out; This is a spontaneous report from a contactable consumer (patient). This 32-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration in the left arm on 29Mar2021 at 10:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no allergies to medications, food or other products. Prior to vaccination the patient was not diagnosed with COVID-19 and had not received any other vaccines in the four weeks prior to the COVID vaccine. Concomitant medications included methadone from an unknown date for an unknown indication. The patient reported that about 36 hours after the first dose she got extremely nauseous. She stated the first time it was diarrhea so bad she thought she was going to pass out. The patient received the second dose of BNT162B2 (lot number unknown) on 19Apr2021 at 10:30. The clinical outcomes of extremely nauseous, and diarrhea so bad she thought she was going to pass out were not recovered. It was also reported that since vaccination the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recv vax & 2-3 days post vax pt devel an inj site rxn characterized by redness, swelling, firmness, pain, warmth over an area the size of a cup;also devel fever & chills for 3 days;arm was sore for 2 wk;
Headache chills fever and pain at the side of injection I was so chilled my teeth were chattering then I got a fever broke out into a sweat
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with M-M-R II (dose, route, lot number and expiration date not provided). The nurse reported that an unspecified number of patients may had received M-M-R II that went through an unsupported temperature excursion. No adverse effects was reported. Additional information is not expected.
This spontaneous report as received from a medical assistant via a company representative refers to a 16 year old female patient.  On 15-JUL-2014 the patient was vaccinated with the first dose of GARDASIL, dose/frequency: 0.5 ml once, (route and lot # not reported). Concomitant therapies included ORTHO TRI-CYCLEN LO. On 16-SEP-2014, the patient reported to office that she had experienced chronic stomach aches since first shot and difficulty eating food (AE onset date was reported as 16-SEP-2014). Patient sought medical attention by  contacting the office. The outcome of events was reported as unresolved. Additional information has been requested.
Warm at Injection site; Pimple; Itchy at injection site; Soreness at Injection site; Rash at Injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm at Injection site), ACNE (Pimple), VACCINATION SITE PRURITUS (Itchy at injection site), VACCINATION SITE PAIN (Soreness at Injection site) and VACCINATION SITE RASH (Rash at Injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     Concomitant products included ZINC, CALCIUM, VITAMIN D3 and LEVOFLOXACIN for an unknown indication.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced VACCINATION SITE WARMTH (Warm at Injection site), ACNE (Pimple), VACCINATION SITE PRURITUS (Itchy at injection site), VACCINATION SITE PAIN (Soreness at Injection site) and VACCINATION SITE RASH (Rash at Injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. In 2021, VACCINATION SITE WARMTH (Warm at Injection site), ACNE (Pimple), VACCINATION SITE PAIN (Soreness at Injection site) and VACCINATION SITE RASH (Rash at Injection site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itchy at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications included over the counter medications, heart pill and sleeping pills for an unknown indication.
Pt had receive.5cc pneumo-vac on 5/3/07 in their Right deltoid. On 5/29/07, pt had reported c/o rash on face, upper chest, and forerms. Pt was given methylprednisolone Injection and methylprednisolone 4mg DOSEPAK,21.
Pt experience neuropathy 3 days after vaccination. Pt reported to us on 10/19/12. He had been seeing MD.
On with the dose 1 want me to sit for 30 mins, because we don't know what your system will do. After 20 mins my blood pressure dropped, and I started feeling really strange and felt like I was about to throw up and they move me to another room. My blood pressure continued to go down and they raised my legs to get the blood to go to my head. Then, my throat started to close and then they gave my 100 mg Benadryl and breathing treatment and they couldn't stabilize me, and they had to call the EMS to transport me to the Hospital ER and Dr. treated me. He said I had an AE to the vaccine. And they monitor me for a few hours and then released me. I had a trouble headache of my life. An then I started having Shingles once or twice a month. In different places on my body and I very fatigued. I have had about four viruses since getting the vaccine. Bad lump swelling in my left arm pit.
Pt recvd immun 14JUN91 & felt nauseated & faint-diaphoresing-po flds given & rested x 40min prior to leaving; 1PM p108, BP 90/40; 110PM p88, BP 88/40; 120PM p80, BP 88/40;
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 11/08/2021. PATIENT FULLY VACCINATED ON 04/09/2021.
3/20/2021   Patient was observed post Covid-19 immunization for 30 minutes based on pre-vaccination screening .  During the observation period, she experienced an adverse reaction with the following symptoms:  urticaria around mouth.   Assessment : Time of assessment 1105am. Alert and oriented. No visible redness , rash, or swelling visualized.   Actions taken: Benadryl 12.5 mg tablet given Po x 1 per standing orders, VS taken with BP- 130/72, P-75, O2 sats- 100%, VS recheck at 1115, BP-122/68, P-72, O2- 100%.       Medications administered: Diphenhydramine (Benadryl) 12.5 ml (25 mg) by mouth. Time: 1105. Administered by RN.   Disposition: Reports no further symptoms of adverse reaction after observation for 30 minutes. Discharged home.     Immunizations Administered    Name Date Dose VIS Date Route   Pfizer COVID-19 Vaccine 3/20/2021 10:40 AM 0.3 mL 12/11/2020 Intramuscular
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. No information about medical history, concurrent conditions and concomitant medications were reported. On 08-JUL-2014 the patient was with her friend (also reported as wife of the reporter) who was vaccinated with ZOSTAVAX on 07-JUL-2014. The reporter stated that the patient developed shingles on an unknown date in July 2014 due to coming in contact with the redness on the patient friend's arm. The patient had taken an unspecified medication for shingles. The outcome of events reported is unknown. This case is linked to the case 1407USA005754 via same reporter link. Additional information has been requested.
diagnosed with shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (diagnosed with shingles) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 149C21A) for COVID-19 vaccination.     Concurrent medical conditions included Stomach pain since April 2021.   On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (diagnosed with shingles). At the time of the report, HERPES ZOSTER (diagnosed with shingles) outcome was unknown.        No relevant concomitant medications were reported. No treatment information was provided.
Herpes Zoster Starting 11/13/2021 on Left Eyebrow  was place on Valtrex 1000mg tablets 3x a day for 7 days
approx 1 hr p/DTP fever of 102.8 R, limp, mottled dusky w/SOB, p80-(RA), BP 130/70 w/good pulse; about 2-3 hrs p/DTP tone, color, activity improved but fever persisted x 48 hrs;
Expired vaccine given to two patients; This case was reported by a physician and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) (batch number unknown, expiry date 30th September 2022) for prophylaxis.   On 8th November 2022, the patient received Havrix. On 8th November 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 08-NOV-2022 Reporter's Comment: The reporter wanted to get the information on the stability of Havrix. The reporter stated that, they had a medical error at the time of reporting wherein a dose of expired vaccine was given to the patient at the time of reporting. The reporter wanted to ask, the data on the stability of this Havrix vaccine after the official expiration date. It had been properly stored since it was arrival at their clinic in a refrigerator whose temperature was monitored daily. Additional Supportive Information: The patient received the expired dose of Havrix, which led to expired vaccine used. This was 1 of 4 cases, reporter by the same reporter.; Sender's Comments:  US-GSK-US2022AMR163515:Same reporter. Patient 1. US-GSK-US2022AMR164695:same reporter US-GSK-US2022163626:same reporter
Admission Date: 10/1/2022 Discharge Date: Oct 2, 2022  PRESENTING PROBLEM: Hypoxia [R09.02] Respiratory failure with hypoxia (HCC) [J96.91] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 52-year-old male with past medical history significant for type 2 diabetes, OSA and chronic diastolic heart failure presented to the emergency department with chief complaint of dyspnea shortness of breath.  Patient was having flu-like symptoms since 09/24/2022, worsening congestion shortness of breath with cough.  Patient was tachycardic and hypoxic on presentation, is placing 4 L of oxygen, he tested positive for COVID-19.  X-ray was negative for acute process, he had CT PE done which was negative for PE.  Patient was treated with DuoNebs, albuterol and dexamethasone.  Patient tolerated well, his tachycardia resolved, he was weaned off oxygen to room air with ambulation, no sputum production.  He was tolerating diet and back to baseline.  Patient was medically stable to be discharged on 10/02/2022 in afternoon.  Was given Decadron prescription for 5 more days.  He was also given prescription for albuterol as needed.  Instructed patient to return to the hospital if he has worsening symptoms.  Patient was vaccinated x2
After receiving the second booster vaccine and sitting down out of the vaccine area, my chest was racing. I felt nauseous. This continued for about five more minutes. I sat down for a total of fifteen minutes after vaccine. No other symptoms felt.
nauseas; hot flashes; slight sore throat; feel a little punk; slight soreness at injection site in my left arm; This is a spontaneous report from a contactable consumer or other non hcp.  A 76-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: Batch/Lot Number: EL9264; Expiration Date: unknown), dose 1 via an unspecified route of administration in Arm Left on 04Feb2021 09:00 as SINGLE DOSE for COVID-19 immunization.  Medical history was unknown. There were no concomitant medications. The patient experienced slight soreness at injection site in my left arm (vaccination site pain) on 04Feb2021 with outcome of recovered, feel a little punk on 08Feb2021 with outcome of unknown, nausea, hot flashes, slight sore throat on 09Feb2021 with outcome of not recovered. The patient is scheduled for the second dose on 25Feb2021.  No follow-up attempts are possible. No information is required.
I got a Tdap vaccine. I'm currently pregnant. Estimated date of delivery is January 27th, 2018. Symptoms are/were headache, tenderness of the arm and injection location, bruising of injection location, swelling, and a knot under the injection location.
Td and varicella immunizations were given on 8/10, but not documented. Patient returned to clinic on 8/18 for vaccines and was given Td and varicella again.
The following morning I experienced severe joint inflammation and sciatica inflammation. The sciatica inflammation went from my right buttock and wrapped all the way down the front of my leg to my ankle. It impaired my ability to walk and on the 11th day I had to go to urgent care and was prescribed muscle relaxers (which did not help) and steroids which eventually aided in being able to walk again normally. This sciatica issue lasted for 17 days. I am still currently experiencing inflammation in my joints especially my knees and elbows.
1) L ant thigh redness swelling 2) unusual behaviors - "Frankenstein-like" walk, walking into walls, grinding teeth, thrusting tongue, crying, sucking on Mom's shoulder
Five days following her first Pfizer COVID vaccine, she woke up from a dead sleep with sharp chest pain, shortness of breath, and feelings of her throat closing. She was given one dose of oral steroids by PCP, but continued to have the feeling that she couldn't breathe due to her throat closing throughout the day so she presented to the ED. There, she reported continued chest pain, worsening SOB, and the feeling that she could not breathe. She was tachycardic to 140 bpm, but otherwise vitals were stable. She was admitted and monitored on continuous telemetry and pulse oximetry overnight. By the following day on 4/29, her symptoms had largely resolved and she was discharged.
fatigue; nausea; This is a spontaneous report from a non-contactable consumer. A 74-years-old male patient received a dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on an unknown date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. Medical history and concomitant medication were not reported. It was unknown whether the patient has received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if prior to vaccination, the patient was diagnosed with COVID-19. It was unknown since the vaccination, if the patient had COVID-19 test. On an unknown patient experienced fatigue and some nausea for 2 days and was back to normal. It was unknown whether the patient received any treatment for the adverse events. The clinical outcome of the events was recovered on unspecified date (reported as back to normal).   No follow-up attempts are possible; information about lot number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: Primary reporter name was added. VAERS Primary reporter Addl Qualification updated as patient per source. Patient's first name updated. The outcome of events was updated as recovered per source.
No other AE; Customer called to report an AE with PROQUAD. The caller said a patient received an expire dose; This spontaneous report has been received from a medical assistant, concerning a patient of unknown gender and age. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions or allergies was unknown.  On 21-MAR-2022, the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) as prophylaxis (lot number T032150 has been verified to be a valid lot, expiration date reported and stablished as 20-MAR-2022) (formulation, strength, exact dose, vaccination scheme, route of administration and anatomical location, lot number and expiration date were not provided) (expired product administered). The vaccine did not experienced any temperature excursion. No adverse events (AE) reported (no adverse event).
Patient with tenderness to injection site with erythema. Ice packs & NSAIDS for fever recommended.
Extreme fatigue, followed by ear pain in right ear on 09/22/2015 in the afternoon. On 09/26/2016 loss of taste in early evening. On 09/27/2015 facial paralysis by PM diagnosed as Bell's Palsy. Treatment is Valtrex and prednisone.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Medial history, concurrent conditions and concomitant medications were not reported. On 10-FEB-2014, the patient was vaccinated with a dose of improperly stored PEDVAXHIB lot # reported as J005672, expiration date reported as 05-DEC-2015 (dose and route were not reported). No adverse experiences were reported. This is one of several repots received from the same reporter. Additional information has been requested.
I had stomach pain on Sunday evening on April 4th. In the morning, I experienced a lot of uncomfortable pain - located in my lower right side. I went to the doctor on the 5th. Then that same day, I went to the ER and I was diagnosed with appendicitis. I spent 2 nights in the ER. My appendix was enlarged. I was given antibiotics. I was discharged on April 7th. I took the antibiotic medication for ten days.
This spontaneous report as received from a doctor of pharmacy concerning a 58 years old male patient with no drug reactions/allergies who on 24-AUG-2012, was vaccinated SQ with a 0.65 ml dose of ZOSTAVAX (lot # not reported). Concomitant medications included LAMICTAL, TRILEPTAL and hydroxyzine. The pharmacist reported that the patient experienced "extreme dry mouth"as of 24-AUG-2012 when he received his shot of ZOSTAVAX. The patient did not have any lab diagnostic performed and any treatment given. The patient sought medical attention-went to the emergency room. At the time of the report, the patient had not recovered. The relatedness for extreme dry mouth for ZOSTAVAX. Additional information has been requested.